BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25008965)

  • 1. Application of enrofloxacin and orbifloxacin disks approved in Japan for susceptibility testing of representative veterinary respiratory pathogens.
    Harada K; Usui M; Asai T
    J Vet Med Sci; 2014 Oct; 76(10):1427-30. PubMed ID: 25008965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
    de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
    Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
    Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
    J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
    Portis E; Lindeman C; Johansen L; Stoltman G
    J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of 12 antibiotics used in veterinary medicine against Mannheimia haemolytica and Pasteurella multocida isolated from calves in the Netherlands].
    Mevius DJ; Hartman EG
    Tijdschr Diergeneeskd; 2000 Mar; 125(5):147-52. PubMed ID: 10730339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
    Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
    Raemdonck DL; Tanner AC; Tolling ST; Michener SL
    Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and temporal trends in antimicrobial resistance of bovine respiratory disease pathogen isolates submitted to the Wisconsin Veterinary Diagnostic Laboratory: 2008-2017.
    Holschbach CL; Aulik N; Poulsen K; Ollivett TL
    J Dairy Sci; 2020 Oct; 103(10):9464-9472. PubMed ID: 32747101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of susceptibility testing of Pasteurella multocida and Mannheimia haemolytica.
    Catry B; Dewulf J; de Kruif A; Vanrobaeys M; Haesebrouck F; Decostere A
    Microb Drug Resist; 2007; 13(3):204-11. PubMed ID: 17949308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle.
    Schwarz S; Kehrenberg C; Salmon SA; Watts JL
    J Antimicrob Chemother; 2004 Feb; 53(2):379-82. PubMed ID: 14729757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.
    Norcia LJ; Seibel SB; Kamicker BJ; Lemay MA; Lilley SC; Hecker SJ; Bergeron JM; Retsema JA; Hayashi SF
    J Antibiot (Tokyo); 1998 Feb; 51(2):136-44. PubMed ID: 9544934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Pelligand L; Toutain PL
    Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media.
    Mead A; Lees P; Mitchell J; Rycroft A; Standing JF; Toutain PL; Pelligand L
    J Vet Pharmacol Ther; 2019 Jan; 42(1):52-59. PubMed ID: 30267412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.